Europe approves new use for Pfizer's Celebrex drug
 Friday, February 23, 2007

Europe approves new use for Pfizer's Celebrex drug

Last Updated: 2007-02-23 10:00:46 -0400 (Reuters Health)

LONDON (Reuters) - Pfizer Inc said on Friday that 17 European countries had agreed to extend the approved use of its Celebrex drug to include symptomatic relief of ankylosing spondylitis in adults.

The decision makes Celebrex the first so-called COX-2 inhibitor to be approved for the disease, a form of arthritis that affects the spine.



Go Back 		 
Schwartzapfel Partners
With over 150 years of combined experience and highly competent co-counsel throughout the country, we can serve all your legal needs. Schwartzapfel Partners protects the rights of those who aren't able to do so themselves.    Learn More



Gender: Male Female
In what state did the incident occur?
Schwartzapfel Truhowsky Marcus
       Sachs P.C. disclaimer.

Clear